US Stock MarketDetailed Quotes

KPTI Karyopharm Therapeutics

Watchlist
  • 8.870
  • +0.307+3.58%
Trading Feb 26 10:38 ET
74.65MMarket Cap-0.64P/E (TTM)

Karyopharm Therapeutics Key Stats

Karyopharm Therapeutics Q4 2024 Earnings Date

Currency:USDFeb 19, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
35.67M
30.54M
-5.13M
Miss Est.
+5.71%
-9.50%
-14.39%
EPS
-4.05
-3.60
+0.45
Beat Est.
+25.00%
+33.33%
+11.11%
Strong Buy

Feb 26, 2025

Karyopharm Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 36.987M--
--2025/Q1-- / 34.816M--
Feb 19, 20252024/Q430.542M / 35.674M--
Nov 5, 20242024/Q338.783M / 37.924M--
Aug 6, 20242024/Q242.786M / 36.213M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 36.987M--
--2025/Q1-- / 34.816M--
Feb 19, 20252024/Q430.542M / 35.674M--
Nov 5, 20242024/Q338.783M / 37.924M--
Aug 6, 20242024/Q242.786M / 36.213M--

Unlock Free Earnings Estimates

Karyopharm Therapeutics Earnings Reports

Read more

Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 26, 2025

Strong Buy

  • Buy

    80.00%
  • Hold

    20.00%
  • Sell

    0.00%

Price Target

No Data